For beginners, this is the comparison that matters most
What makes tesamorelin stand out clinically is that its active peptide was FDA-validated through EGRIFTA SV, the brand-name drug approved specifically for excess visceral fat in HIV patients with lipodystrophy
GLP1 RAs also pair well with SGLT2 inhibitors, offering complementary benefits without overlapping side effects
[39] likewise found significantly lower rates of CSF shunt procedures in the GLP-1 RA group (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide, albiglutide) compared to controls ( 1.8% vs
However, GLP-1 drugs are costly
Bone outcomes following sleeve gastrectomy in adolescents and young adults with obesity versus non-surgical controls